Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:52:14.915Z.
Calculation as of: 2026-10-06T18:52:14.915Z.
Quote observation: 2026-10-06T18:49:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 65e01e2061821370315a71c231e2ba412a336584d38d2dbcbde0d0d1c3e2cd16
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Mobia Medical, Inc. Common Stock
Market Cap
$299.57M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$303.69M
EV/EBIT Ratio
N/A
TTM Avg
23.87x
3Y Avg
23.87x
5Y Avg
23.87x
Market Cap
$287.63M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$283.92M
EV/EBIT Ratio
N/A
TTM Avg
15.89x
3Y Avg
15.15x
5Y Avg
15.15x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $299.57M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $303.69M | N/A | 23.87x | 23.87x | 23.87x |
| Larimar Therapeutics, Inc. (LRMR)vs › | $291.71M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $287.63M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $286.40M | N/A | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $313.46M | N/A | N/A | N/A | N/A |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.42M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $285.38M | N/A | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $283.92M | N/A | 15.89x | 15.15x | 15.15x |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $283.18M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
